These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37998809)

  • 1. Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development.
    Pavlova N; Traykovska M; Penchovsky R
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Antisense Oligonucleotides as Antibacterial Agents That Target FMN Riboswitches and Inhibit the Growth of
    Traykovska M; Penchovsky R
    ACS Synth Biol; 2022 May; 11(5):1845-1855. PubMed ID: 35440139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SAM-I Riboswitch Using Antisense Oligonucleotide Technology for Inhibiting the Growth of
    Traykovska M; Penchovsky R
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting TPP Riboswitches Using Chimeric Antisense Oligonucleotide Technology for Antibacterial Drug Development.
    Traykovska M; Otcheva LA; Penchovsky R
    ACS Appl Bio Mater; 2022 Sep; ():. PubMed ID: 36170638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glmS Ribozyme with Chimeric Antisense Oligonucleotides for Antibacterial Drug Development.
    Traykovska M; Popova KB; Penchovsky R
    ACS Synth Biol; 2021 Nov; 10(11):3167-3176. PubMed ID: 34734706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteria.
    Pavlova N; Penchovsky R
    Expert Opin Ther Targets; 2019 Jul; 23(7):631-643. PubMed ID: 31079546
    [No Abstract]   [Full Text] [Related]  

  • 7. General and Specific Cytotoxicity of Chimeric Antisense Oligonucleotides in Bacterial Cells and Human Cell Lines.
    Popova KB; Penchovsky R
    Antibiotics (Basel); 2024 Jan; 13(2):. PubMed ID: 38391508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs.
    Deigan KE; Ferré-D'Amaré AR
    Acc Chem Res; 2011 Dec; 44(12):1329-38. PubMed ID: 21615107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riboswitches as Drug Targets for Antibiotics.
    Panchal V; Brenk R
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33466288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Investigation into the Potential of Targeting
    Goddard LR; Mardle CE; Gneid H; Ball CG; Gowers DM; Atkins HS; Butt LE; Watts JK; Vincent HA; Callaghan AJ
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application of Cell-Penetrating-Peptides in Antibacterial Agents.
    Chen H; Battalapalli D; Draz MS; Zhang P; Ruan Z
    Curr Med Chem; 2021; 28(29):5896-5925. PubMed ID: 34225605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
    Wang H; Mann PA; Xiao L; Gill C; Galgoci AM; Howe JA; Villafania A; Barbieri CM; Malinverni JC; Sher X; Mayhood T; McCurry MD; Murgolo N; Flattery A; Mack M; Roemer T
    Cell Chem Biol; 2017 May; 24(5):576-588.e6. PubMed ID: 28434876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboswitches as therapeutic targets: promise of a new era of antibiotics.
    Ellinger E; Chauvier A; Romero RA; Liu Y; Ray S; Walter NG
    Expert Opin Ther Targets; 2023; 27(6):433-445. PubMed ID: 37364239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics and Genomic Analyses of the Suitability of Eight Riboswitches for Antibacterial Drug Targets.
    Pavlova N; Penchovsky R
    Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSwitch: A Novel Bioinformatics Database on Riboswitches as Antibacterial Drug Targets.
    Penchovsky R; Pavlova N; Kaloudas D
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):804-808. PubMed ID: 32248122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense and Functional Nucleic Acids in Rational Drug Development.
    Penchovsky R; Georgieva AV; Dyakova V; Traykovska M; Pavlova N
    Antibiotics (Basel); 2024 Feb; 13(3):. PubMed ID: 38534656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression.
    Lee ER; Blount KF; Breaker RR
    RNA Biol; 2009; 6(2):187-94. PubMed ID: 19246992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of riboswitches as potential antibacterial drug targets.
    Lünse CE; Schüller A; Mayer G
    Int J Med Microbiol; 2014 Jan; 304(1):79-92. PubMed ID: 24140145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel targets for antibiotics discovery: riboswitches].
    Jia DF; Jia DF; Jia DF
    Yao Xue Xue Bao; 2013 Sep; 48(9):1361-8. PubMed ID: 24358767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases.
    Xue XY; Mao XG; Zhou Y; Chen Z; Hu Y; Hou Z; Li MK; Meng JR; Luo XX
    Nanomedicine; 2018 Apr; 14(3):745-758. PubMed ID: 29341934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.